PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication

Journal of Cell Science

Volumn 124, Issue 2, 2011, Pages 280-291

  Cuchet, Delphine ^a   Sykes, Amanda ^a   Nicolas, Armel ^a   Orr, Anne ^a   Murray, Jill ^a   Sirma, Hüseyin ^b   Heeren, Joerg ^c   Bartelt, Alexander ^c   Everett, Roger D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

HSV 1; ICP0; ND10; PML

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN 1; PROMYELOCYTIC LEUKEMIA PROTEIN 2; PROTEIN SP100; PROTEIN TRIM; SUMO PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS REGULATORY PROTEIN ICP0;

ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN RESTRICTION; VIRUS REPLICATION;

AMINO ACID MOTIFS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; SUMOYLATION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1;

EID: 79251547017     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.075390     Document Type: Article

References (68)

1. Beech, S. J., Lethbridge, K. J., Killick, N., McGlincy, N. and Leppard, K. N. (2005). Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization. Exp. Cell Res. 307, 109-117.
2. Bernardi, R. and Pandolfi, P. P. (2003). Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22, 9048-9057.
3. Bernardi, R. and Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006-1016.
4. Bischof, O., Kirsh, O., Pearson, M., Itahana, K., Pelicci, P. G. and Dejean, A. (2002). Deconstructing PML-induced premature senescence. EMBO J. 21, 3358-3369.
5. Block, G. J., Eskiw, C. H., Dellaire, G. and Bazett-Jones, D. P. (2006). Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies. Mol. Cell. Biol. 26, 8814-8825.
6. Boisvert, F. M., Kruhlak, M. J., Box, A. K., Hendzel, M. J. and Bazett-Jones, D. P. (2001). The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152, 1099-1106.
7. Borden, K. L. (2002). Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269.
8. Boutell, C., Orr, A. and Everett, R. D. (2003). PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J. Virol. 77, 8686-8694.
9. Brand, P., Lenser, T. and Hemmerich, P. (2010). Assembly dynamics of PML nuclear bodies in living cells. PMC Biophys. 3, 3.
10. Cantrell, S. R. and Bresnahan, W. A. (2006). Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J. Virol. 80, 6188-6191.
11. Chang, K. S., Fan, Y. H., Andreeff, M., Liu, J. and Mu, Z. M. (1995). The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85, 3646-3653.
12. Chelbi-Alix, M. K. and de The, H. (1999). Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18, 935-941.
13. Condemine, W., Takahashi, Y., Zhu, J., Puvion-Dutilleul, F., Guegan, S., Janin, A. and de The, H. (2006). Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res. 66, 6192-6198.
14. Condemine, W., Takahashi, Y., Le Bras, M. and de The, H. (2007). A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J. Cell Sci. 120, 3219-3227.
15. Dellaire, G. and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26, 963-977. (Pubitemid 39273070)
16. Dellaire, G., Eskiw, C. H., Dehghani, H., Ching, R. W. and Bazett-Jones, D. P. (2006). Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J. Cell Sci. 119, 1034-1042.
17. Eskiw, C. H. and Bazett-Jones, D. P. (2002). The promyelocytic leukemia nuclear body: sites of activity? Biochem. Cell Biol. 80, 301-310.
18. Eskiw, C. H., Dellaire, G., Mymryk, J. S. and Bazett-Jones, D. P. (2003). Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J. Cell Sci. 116, 4455-4466. (Pubitemid 37369600)
19. Everett, R. D. (1983). DNA sequence elements required for regulated expression of the HSV-1 glycoprotein D gene lie within 83 bp of the RNA capsites. Nucleic Acids Res. 11, 6647-6666.
20. Everett, R. D. (2001). DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273.
21. Everett, R. D. and Zafiropoulos, A. (2004). Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection. J. Virol. 78, 11411-11415.
22. Everett, R. D. and Chelbi-Alix, M. K. (2007). PML and PML nuclear bodies: Implications in antiviral defence. Biochimie 89, 819-830.
23. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. and Parkinson, J. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72, 6581-6591.
24. Everett, R. D. and Murray, J. (2005). ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79, 5078-5089.
25. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R. and Orr, A. (1999). Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
26. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T. and Orr, A. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80, 7995-8005.
27. Everett, R. D., Murray, J., Orr, A. and Preston, C. M. (2007). Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J. Virol. 81, 10991-11004.
28. Everett, R. D., Parada, C., Gripon, P., Sirma, H. and Orr, A. (2008a). Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J. Virol. 82, 2661-2672.
29. Everett, R. D., Young, D. F., Randall, R. E. and Orr, A. (2008b). STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J. Virol. 82, 8871-8881.
30. Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C. and Guguen-Guillouzo, C. (2002). Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99, 15655-15660. (Pubitemid 35403987)
31. Hayakawa, F. and Privalsky, M. L. (2004). Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell 5, 389-401.
32. Hoppe, A., Beech, S. J., Dimmock, J. and Leppard, K. N. (2006). Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J. Virol. 80, 3042-3049.
33. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F. and Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234.
34. Jamieson, D. R. S., Robinson, L. H., Daksis, J. I., Nicholl, M. J. and Preston, C. M. (1995). Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus Vmw65 mutants. J. Gen. Virol. 76, 1417-1431.
35. Jensen, K., Shiels, C. and Freemont, P. S. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223-7233.
36. Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T. and Yeh, E. T. (1998a). Identification of three major sentrinization sites in PML. J. Biol. Chem. 273, 26675-26682.
37. Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T. and Yeh, E. T. (1998b). Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J. Biol. Chem. 273, 3117-3120.
38. Kyratsous, C. A. and Silverstein, S. J. (2009). Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. J. Virol. 83, 4262-4274.
39. Lee, H. R., Kim, D. J., Lee, J. M., Choi, C. Y., Ahn, B. Y., Hayward, G. S. and Ahn, J. H. (2004). Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J. Virol. 78, 6527-6542.
40. Leppard, K. N., Emmott, E., Cortese, M. S. and Rich, T. (2009). Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis. J. Gen. Virol. 90, 95-104.
41. Ling, P. D., Tan, J., Sewatanon, J. and Peng, R. (2008). Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J. Virol. 82, 8000-8012.
42. Lopez, P., Jacob, R. J. and Roizman, B. (2002). Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins. J. Virol. 76, 9355-9367.
43. Lukashchuk, V., McFarlane, S., Everett, R. D. and Preston, C. M. (2008). Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 82, 12543-12554.
44. Lukashchuk, V., Orr, A. and Everett, R. D. (2010). Regulation of ICP0 null mutant HSV-1 infection by ND10 components ATRX and hDaxx. J. Virol. 84, 4026-4040.
45. Maul, G. G. (1998). Nuclear domain 10, the site of DNA virus transcription and replication. BioEssays 20, 660-667.
46. McNally, B. A., Trgovcich, J., Maul, G. G., Liu, Y. and Zheng, P. (2008). A role for cytoplasmic PML in cellular resistance to viral infection. PLoS ONE 3, e2277.
47. Negorev, D. and Maul, G. G. (2001). Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7242.
48. Negorev, D. G., Vladimirova, O. V., Ivanov, A., Rauscher, F., 3rd and Maul, G. G. (2006). Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J. Virol. 80, 8019-8029.
49. Pichler, A., Gast, A., Seeler, J. S., Dejean, A. and Melchior, F. (2002). The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109-120.
50. Preston, C. M. and Nicholl, M. J. (2006). Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J. Gen. Virol. 87, 1113-1121.
51. Reineke, E. L. and Kao, H. Y. (2009). Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. Int. J. Biol. Sci. 5, 366-376.
52. Saffert, R. T. and Kalejta, R. F. (2006). Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 80, 3863-3871.
53. Scaglioni, P. P., Yung, T. M., Cai, L. F., Erdjument-Bromage, H., Kaufman, A. J., Singh, B., Teruya-Feldstein, J., Tempst, P. and Pandolfi, P. P. (2006). A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126, 269-283.
54. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M. and Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol. Cell 24, 331-339.
55. Sobol, P. T., Hummel, J. L., Rodrigues, R. M. and Mossman, K. L. (2009). PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses. Gene Ther. 16, 1077-1087.
56. Sternsdorf, T., Guldner, H. H., Szostecki, C., Grotzinger, T. and Will, H. (1995). Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol. 42, 257-268.
57. Sternsdorf, T., Jensen, K. and Will, H. (1997). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621-1634. (Pubitemid 28079228)
58. Stow, N. D. and Stow, E. C. (1986). Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67, 2571-2585.
59. Stuurman, N., de Graaf, A., Floore, A., Josso, A., Humbel, B., de Jong, L. and van Driel, R. (1992). A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101, 773-784.
60. Sykes, A. K. (2007). An investigation into the roles of the major PML isoforms in HSV-1 infection. PhD thesis, University of Glasgow.
61. Tatham, M. H., Kim, S., Jaffray, E., Song, J., Chen, Y. and Hay, R. T. (2005). Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat. Struct. Mol. Biol. 12, 67-74.
62. Tavalai, N., Papior, P., Rechter, S., Leis, M. and Stamminger, T. (2006). Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J. Virol. 80, 8006-8018.
63. Tavalai, N., Papior, P., Rechter, S. and Stamminger, T. (2008). Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 82, 126-137.
64. Weidtkamp-Peters, S., Lenser, T., Negorev, D., Gerstner, N., Hofmann, T. G., Schwanitz, G., Hoischen, C., Maul, G., Dittrich, P. and Hemmerich, P. (2008). Dynamics of component exchange at PML nuclear bodies. J. Cell Sci. 121, 2731-2743.
65. Wiesmeijer, K., Molenaar, C., Bekeer, I. M., Tanke, H. J. and Dirks, R. W. (2002). Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J. Struct. Biol. 140, 180-188.
66. Woodhall, D. L., Groves, I. J., Reeves, M. B., Wilkinson, G. and Sinclair, J. H. (2006). Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J. Biol. Chem. 281, 37652-37660.
67. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A. and Pandolfi, P. P. (2000a). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.
68. Zhong, S., Salomoni, P. and Pandolfi, P. P. (2000b). The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2, E85-E90.